CLOVER HEALTH INVESTMENTS, CORP. /DE Lease, Cost
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) reported Lease, Cost of $487.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2026-02-27
- CLOVER HEALTH INVESTMENTS, CORP. /DE lease, cost for the quarter ending 2021-12-31 was $638.00K.
- CLOVER HEALTH INVESTMENTS, CORP. /DE lease, cost for the quarter ending 2021-09-30 was $614.00K.
- CLOVER HEALTH INVESTMENTS, CORP. /DE lease, cost for the quarter ending 2021-06-30 was $571.00K.
- CLOVER HEALTH INVESTMENTS, CORP. /DE lease, cost for the quarter ending 2021-03-31 was $528.00K.
- CLOVER HEALTH INVESTMENTS, CORP. /DE lease, cost for fiscal 2025 was $487.00K, a 14.71% decline from fiscal 2024.
- CLOVER HEALTH INVESTMENTS, CORP. /DE lease, cost for fiscal 2024 was $571.00K, a 49.96% decline from fiscal 2023.
- CLOVER HEALTH INVESTMENTS, CORP. /DE lease, cost for fiscal 2023 was $1.14M, a 27.92% decline from fiscal 2022.
- CLOVER HEALTH INVESTMENTS, CORP. /DE lease, cost for fiscal 2022 was $1.58M, a 32.58% decline from fiscal 2021.
| Period end | Lease, Cost 3 month | Lease, Cost 6 month | Lease, Cost 9 month | Lease, Cost 12 month |
|---|---|---|---|---|
| 2025-12-31 | $487.00K 10-K · filed 2026-02-27 | |||
| 2024-12-31 | $571.00K 10-K · filed 2026-02-27 | |||
| 2023-12-31 | $1.14M 10-K · filed 2026-02-27 | |||
| 2022-12-31 | $1.58M 10-K · filed 2025-03-03 | |||
| 2021-12-31 | $638.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $1.25M derived: sum of 2 quarters · filed 2024-03-14 | $1.82M derived: sum of 3 quarters · filed 2024-03-14 | $2.35M 10-K · filed 2024-03-14 |
| 2021-09-30 | $614.00K 10-Q · filed 2021-11-09 | $1.19M derived: sum of 2 quarters · filed 2021-11-09 | $1.71M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $571.00K 10-Q · filed 2021-08-11 | $1.10M 10-Q · filed 2021-08-11 | ||
| 2021-03-31 | $528.00K 10-Q · filed 2021-05-17 | |||
| 2020-12-31 | $2.09M 10-K · filed 2023-03-01 | |||
| 2019-12-31 | $4.28M 10-K · filed 2022-02-28 |